top of page


Dr. Bella Manshian
profile picture Bella.jpg

Bella Manshian is a group leader at the Nanohealth and Optical Imaging group at KU Leuven. Bella’s research focuses on nanotoxicology and the manipulation of nanomaterials for in vivo theranostic applications. Bella has been using multimodal and multiparametric in-vivo imaging, of mainly preclinical animal models, to assess disease mechanisms and therapy accompanied with screening of individual nanoparticle toxicity, the mechanisms involved and cellular-nanoparticle interaction kinetics. Bella’s main interest is in developing non-invasive methods for the dual function of visualization and tracking of specific cell types with a strong focus on tumor cell, stem cells, immune cells and beta cells while simultaneously delivering therapeutic agents.

bottom of page